Recent studies have proposed that tumor-specific tumor-infiltrating CD8 + T lymphocytes (CD8 TIL) can be classified into two main groups: "exhausted" TILs, characterized by high expression of the inhibitory receptors PD-1 and TIM-3 and lack of transcription factor 1 (Tcf1); and "memory-like" TILs, with self-renewal capacity and co-expressing Tcf1 and PD-1. However, a comprehensive definition of the heterogeneity existing within both tumor-specific and total CD8 TILs has yet to be clearly established.
INTRODUCTION
Chronic antigen stimulation and inflammation lead to CD8 T cell differentiation and function that differ from those generated during acute infections. Chronically stimulated CD8 T cells acquire an "exhausted" state characterized by a progressive loss of cytolytic activity, reduced cytokine production and proliferative capacity, upregulation of multiple co-inhibitory receptors, such as PD-1, CTLA4, LAG3, TIGIT and TIM3, and a unique epigenetic state (Mclane, Abdel-Hakeem and Wherry, 2019) .
Although initially considered hypofunctional effector T cells, several observations
suggest that exhausted T cells are heterogeneous and have crucial roles in limiting viral infection or tumor growth while avoiding damage to normal tissues (Speiser et al., 2014 ). Yet, antigen-specific T cells in tumors often lack effector function and fail to control tumor growth and therefore they are also referred to as "dysfunctional" (Li et al., 2019; Philip and Schietinger, 2019) . Notwithstanding, immune-checkpoint blockade (ICB) therapies using anti-PD-1 can result in a proliferative response of CD8 tumor-infiltrating lymphocytes (TILs) and improve effector functions (Tumeh et al., 2014) .
Understanding how anti-PD-1 therapy affects distinct CD8 TIL subsets is a major challenge in cancer immunotherapy. Recently, a novel intratumoral tumor-specific CD8 T cell subpopulation was discovered among murine TILs that mediates cellular expansion in response to immune checkpoint blockade (Miller et al., 2019; Siddiqui et al., 2019) . These cells have been isolated and characterized using different combinations of surface markers and reporter genes (e.g. PD-1 + Tcf7:GFP + and PD-1 + TIM3 -SLAMF6 + ) and were named "memory-like" (Siddiqui et al., 2019) or "progenitor exhausted" (Miller et al., 2019) . Memory-like CD8 TILs cells have the capacity to expand, self-renew and give rise to terminally differentiated cells (PD-1 + TIM3 + Tcf1 -, GZMB + ; termed "exhausted") in the context of chronic antigenic stimulation, similarly to progenitor CD8 T cell subsets previously described in chronic infection (He et al., 2016; Im et al., 2016; Utzschneider et al., 2016; Wu et al., 2016; Kallies, Zehn and Utzschneider, 2019) . However, there are still many unknowns regarding how T cells committed to the exhaustion lineage develop from pre-exhausted T cell states and which of these states are present in the tumor. Therefore, a comprehensive definition of the heterogeneity existing within both tumor-specific and total CD8 TILs has yet to be clearly established.
Here we aimed at defining a reference transcriptomic map and determining clonal relatedness of CD8 TILs, including cells of known tumor-specificity, in the common B16 murine melanoma model. To this aim, we have sequenced the transcriptome including full-length T cell receptor genes of >3500 single-cell CD8 TILs from seven tumor-bearing mice including wild-type C57BL/6 and PMEL transgenic mice.
Furthermore, to study how the CD8 TIL landscape is modulated by immunotherapy, we performed a meta-analysis of published bulk and single-cell RNA-seq (scRNA-seq) data. Our study provides new insights into the heterogeneity of CD8 TILs, including novel markers to define T cell subpopulations, as well as freely accessible bioinformatics tools to guide the analysis of scRNA-seq data sets.
RESULTS

Single-cell RNA-seq of CD8 TILs reveals the presence of exhausted, memory-like, naïve and effector memory-like T cells
To obtain an unbiased view of the transcriptomic landscape of tumor-infiltrating CD8 T cells from B16 melanoma tumor-bearing mice, we performed single-cell transcriptomic profiling paired with VDJ locus sequencing of CD8 TILs. We individually analyzed 4 wild-type (WT) C57BL/6 mice and 3 PMEL transgenic mice, whose CD8 T cells express a transgenic TCR specific for the B16 tumor-associated antigen gp100/PMEL (Figure 1 A) . After data processing and quality control, >3500 CD8 T cells from the 7 tumors were kept for downstream analyses (See Methods).
Unsupervised clustering on the high-dimensional space revealed the presence of four robust CD8 TIL clusters with distinct transcriptomic profiles. Cluster 1 (C1) was defined by high expression of inhibitory receptors Pdcd1, Havcr2, Ctla4, Tigit and Lag3, exhaustion-related transcription factors such as Batf and Tox (Alfei et al., 2019; Khan et al., 2019; Scott et al., 2019; Yao et al., 2019) and high expression of cytotoxic molecules (e.g. Gzmb, Prf1, Fasl) , compatible with an exhausted state (Figure 1 B,C) .
Cluster 2 (C2), in proximity to C1, was defined by the co-expression of inhibitory receptors (expressing Pdcd1, Tigit and Lag3 but not Havcr2 or Entpd1) and memory related genes (e.g. Tcf7, Lef1, Sell) , and low levels of cytotoxicity genes (Figure 1 B,C) , compatible with the recently described memory-like subset (Miller et al., 2019; Siddiqui et al., 2019) . Cluster 3 (C3) was defined by high expression of markers of naïve/memory (e.g. Tcf7, Sell, Ccr7, Lef1, Il7r) and no expression of cytotoxicity genes or inhibitory receptors, compatible with a naïve or central memory state (Figure 1 B , C). Based on the lack of Cd44 expression in this cluster (Figure 1 C) we provisionally refer to it as naïve cells cluster. Finally, cells in cluster 4 (C4) expressed high levels of memory-related genes (e.g. Tcf7, Lef1, Il7r) together with cytotoxicity genes (e.g.
Gzmk, Gzmb). Compared to the memory-like C2, C4 was characterized by low expression of the inhibitory receptors Pdcd1, Tigit, Lag3 and the exhaustion-related transcription factors Tox and Batf (Figure 1 
C). Expression of granzymes and lack of
Sell and Ccr7 expression suggested an effector memory rather than a central memory phenotype (Figure 1 C) . Hence, this cluster was referred to as Effector Memory-like ("EM-like") state (Figure 1 B,C) . Note that, while T cells with effector memory phenotype have been previously observed among TILs (Zhang et al., 2018; Haas et al., 2019) , EM-like cells have never been characterized at the transcriptomic level on murine tumors, and a gene signature for this population remains to be defined.
Differentially expressed genes in each cluster are shown in Supplemental Table 1 . Gene expression differences between these four clusters could be further summarized by the expression of three gene sets associated with 1) cytotoxicity (Gzmb, Prf1 and Fasl), 2) inhibition/exhaustion (Pdcd1, Havcr2, Tigit, Lag3, Ctla4) and 3) "stemness" (Tcf7, Sell, Il7r, Lef1). While the naïve cluster (C3) presented the highest level of stemness and the lowest inhibition and cytotoxicity, the exhausted cluster (C1) presented the lowest levels of stemness with the highest levels of inhibition and cytotoxicity (Figure 1 D). The memory-like (C2) cluster displayed higher levels of "stemness" compared to exhausted, together with lower levels of inhibition and very low levels of cytotoxicity, in line with previous observations (Miller et al., 2019; Siddiqui et al., 2019) . Instead, the EM-like (C4) cluster displayed intermediate levels of cytotoxicity and "stemness", with low levels of inhibition (Figure 1 D) . We next evaluated to what extent these CD8 TIL states relate to previously described CD8 T cell subsets found in the context of cancer or infection. An initial gene signature enrichment analysis confirmed that C3 matched the transcriptomic state of splenic naïve T cells (Sarkar et al., 2008) , while the other three clusters up-regulated genes associated with differentiated CD8 T cells (Supplemental Figure 1 , see Methods). Next, we focused on the three differentiated states to evaluate signature enrichment against specific CD8 T cell subtypes. We found a consistent mapping of the memory-like (C2) cluster with the tumor-resident PD-1 + Tcf1 + "memory-like" subset (Siddiqui et al., 2019) (Figure 1 E) , whereas the exhausted cluster (C1) was mapped to the "exhausted" PD-1 + Tcf1subset described in the same study. Further, these two clusters also matched the memory-like and exhausted subsets, respectively, found in chronic infection (Figure 1 E) .
The EM-like cluster did not match the exhausted nor the memory-like signatures, and instead showed specific enrichment for the signature of pathogen-specific CD8 T cells found upon acute infection ("Tumor vs acute infection -DOWN", row 6 in Figure 1 E) (Schietinger et al., 2016) . Further, among pathogen-specific CD8 T cells found upon acute infection, the EM-like cluster was specifically enriched in the signature of tumors, we analyzed this cluster in more detail. Differential gene expression analysis of EM-like vs exhausted and memory-like cells revealed potential novel markers for this population (Figure 1 F) , including Ly6c2 that encodes a surface molecule that has been previously associated to memory CD8 T cells (Walunas et al., 1995; Pihlgren, 1996; Cerwenka et al., 1998) and Cxcr3, a chemokine receptor that guides the recruitment of T cells into inflamed peripheral tissue (Groom and Luster, 2011) .
Next, we analyzed how CD8 TIL states were distributed among WT and PMEL mice, i.e. according to antigen-specificity. We found that T cell from both types of mice were present in all four states ( The robustness of the four identified transcriptomic states was confirmed by unsupervised clustering of an independent publicly available scRNA-seq dataset of CD8 TILs from B16 melanoma tumors , where a consistent cluster correspondence was verified between datasets (Supplemental Figure 3 ). Furthermore, re-analysis of a recently published scRNA-seq dataset of tumor-specific CD8 TILs in B16-OVA tumors (Miller et al., 2019) revealed the presence of EM-like cells (12% among OVA Tetramer + CD8 TILs) in addition to memory-like (11%) and exhausted (76%) cells (Supplemental Figure 4 ), further supporting that part of the EM-like subset contains tumor-specific cells.
Overall, we were able to define the landscape of transcriptomic states of endogenous CD8 TILs in B16 melanoma tumors and recapitulate the naïve, memory-like and exhausted CD8 TIL subsets through an unbiased analysis of single-cell heterogeneity.
Moreover, we observed that among total CD8 TILs the most prominent subset corresponded to a transcriptomically distinct state that resembles that of effector memory T cells found in the context of acute infections.
EM-like cells can be identified as Tcf1 high PD-1 intermediate CD8 TILs by flow cytometry
Our scRNA-seq data showed that the levels of Tcf7 (encoding Tcf1) expression were high among naïve, memory-like and EM-like, and zero among exhausted cells ( Figure   2 A). Pdcd1 (encoding PD-1) expression was highest in exhausted and memory-like, intermediate in EM-like and absent in naïve CD8 TILs (Figure 2 A). To validate these observations at the protein level, we performed flow cytometry analysis of CD8 TILs infiltrating B16 tumors at day 12 post tumor engraftment. In agreement with previous studies (Thompson et al., 2010) and consistently with our scRNA-seq data, we found both naïve (CD44 low , 4 to 20%) and antigen-experienced (CD44 high ) cells among CD8 TILs. Next, CD44 high CD8 TILs were classified into four compartments according to Tcf1 and PD-1 expression: Tcf1 low PD-1 high (~9% on average), Tcf1 high PD-1 high (~31%) and Tcf1 high cells with low (~21%) or intermediate (~30%) PD-1 levels ( Figure 2 ).
According to the transcriptomic profiles and in line with previous evidence (Miller et al., 2019; Siddiqui et al., 2019) , exhausted cells are mostly found in the Tcf1 low PD-1 high compartment and memory-like cells in the Tcf1 high PD-1 high gate. From our transcriptomics data EM-like cells were predicted to be in the Tcf1 
Exhausted, Memory-like and EM-like CD8 TILs are clonally expanded and show partial clonal relatedness
In order to assess the clonal relatedness of CD8 TILs states, we analyzed TCR alpha and beta chain sequences in the >3500 single-cells shown in Figure 1 B (see Methods).
We obtained full-length productive paired alpha and beta chains sequences (VJ or VDJ, respectively) in 81% of the CD8 TILs (Figure 3 A) .
In each WT mouse, we identified T cells of the same clonotype, i.e. those expressing identical CDR3s for both alpha and beta T cell receptor chains. We found that between 10 and 39% of the TILs were expanded (i.e. their TCR were shared with at least another T cell in the same mouse). As expected, less than 1% of expanded T cells were found in the naïve state (Figure 3 B) . In contrast, 68% of the T cells were expanded in the exhausted state, 52% in the EM-like state and 39% in the memory-like state. Expanded clonotypes did not match reported invariant chains and no known epitopes were found for these TCRs by literature and database searches. Furthermore, clonotypes in WT mice were largely private (mouse-specific) (see Methods and Supplemental Figure 5 ).
As a control, a large clonal overlap was observed between different PMEL mice, due to the common transgenic PMEL TCR (Supplemental Figure 5 ).
Next, we evaluated TCR repertoire overlap between transcriptomic states. To this aim, we assessed TCR repertoire similarity using the Morisita-Horn (MH) similarity index that considers the relative frequencies of clonotypes between samples, where 0 indicates no overlap, and 1 is an exact match (Weinberger et al., 2015) . Interestingly, this analysis revealed that exhausted and memory-like states had a considerable These results show that single clonotypes span both exhausted and memory-like states, in line with recent studies demonstrating that memory-like T cells can give rise to exhausted T cells in the tumor (Miller et al., 2019; Siddiqui et al., 2019) . Furthermore, although EM-like and exhausted states presented largely distinct TCR repertoires, some clones were present in both, suggesting that occasionally EM-like cells (most likely tumor-specific) may yield exhausted T cells, yet to a lesser degree than the memorylike state. 
PD-1 checkpoint blockade expands EM-like cells
Multiple studies have established that PD-1 blockade expands intratumoral T cells and improves tumor control (Curran et al., 2010; Wei et al., 2017; Gubin et al., 2018; Gide et al., 2019) . However, it is less clear how different CD8 T cell states are affected by immune-checkpoint blockade (ICB). Hence, here we aimed at evaluating the impact of ICB on the murine CD8 TIL transcriptomic landscape. To this end, we first extracted gene signatures of the exhausted, memory-like and EM-like states from our scRNAseq dataset (Figure 4 A and Supplemental Table 1 ). Next, we performed gene-set enrichment analysis (GSEA) on published bulk RNA-seq data of CD8 TILs following anti-PD-1 therapy (raw data in murine sarcoma from (Gubin et al., 2014) . Our results indicated that ICB led to a selective enrichment of the EM-like signature (p=0.035, Figure 6 A, raw data from (Markowitz et al., 2018) ).
In order to assess whether the bulk transcriptomic signature shift towards the EM-like state upon ICB is explained by differences in CD8 TIL states composition, we reanalyzed publicly available scRNA-seq data of CD8 TILs pre vs post ICB. To this aim, we developed a machine learning tool, named TILPRED, that predicts CD8 TIL states according to our definition (see Methods). TILPRED analysis of CD8 TIL scRNA-seq data from murine sarcoma ) and MC38 colon adenocarcinoma (Gubin et al., 2014) ).
NES=Normalized Enrichment Score. C tSNE plot of global transcriptomic similarity of CD8 TILs from murine sarcoma upon PD-1 blockade (dataset from ); D tSNE plot of global transcriptomic similarity of CD8 TILs from MC38 colon adenocarcinoma upon PD-1 and TIM3 blockade (dataset from , contains only PD-1 low TILs).
Cell colors represent TIL state predictions by TILPRED.
DISCUSSION
In the past few years, single-cell transcriptomics and mass cytometry studies have revealed a large complexity of CD8 T cells in the tumor microenvironment, including multiple cellular states that have been referred to as exhausted, memory, naïve, effector, effector memory, etc., and this heterogeneity is likely to be a determining factor in therapy outcome (Tirosh et al., 2016; Chevrier et al., 2017; Kang et al., 2017;  CD8 TIL state composition CD8 TIL state composition
Havcr2
Tnfrsf9 Txn1 Mt1 Brummelman et al., 2018; Guo et al., 2018; Jerby-Arnon et al., 2018; Zhang et al., 2018; Li et al., 2019; Yost et al., 2019) . However, as biological variability between patients and clinical samples is very large and tumor-specificity of T cells is rarely known, it is also crucial to define robust and unbiased tumor-infiltrating T cell transcriptomic states in murine models. Indeed, very recent studies in B16 murine melanoma model have shown that tumor-specific CD8 TILs can be found in the exhausted (PD-1 + TCF1 -) and memory-like ("stem-like" PD-1 + TCF1 + ) states (Miller et al., 2019; Siddiqui et al., 2019) .
Here we have defined a reference transcriptomic map of CD8 TILs in the common B16 melanoma model. Our single-cell RNA-seq analysis enabled us to robustly and unbiasedly define four distinct CD8 TIL transcriptomic states: exhausted, memory-like, naïve and effector memory-like (EM-like).
Consistently with previous observations, tumor-specific PMEL TILs were enriched in exhausted and memory-like states (Miller et al., 2019; Siddiqui et al., 2019) . In contrast, total polyclonal CD8 TILs were enriched in the EM-like and naïve states.
Therefore, an intriguing question is why the EM-like population is abundant in the endogenous polyclonal CD8 TIL compartment, but small among tumor-specific cells.
A likely explanation is that the EM-like compartment is enriched in non tumor-specific cells, as multiple studies have shown the presence of large numbers of "bystander" T cells in human tumors (Simoni et al., 2018; Scheper et al., 2019) Figure 6 D) , which is essential to establish and maintain the epigenetic T cell exhaustion program enabling T cells to persist in the context of chronic antigenic stimulation (Alfei et al., 2019; Khan et al., 2019; Scott et al., 2019; Yao et al., 2019) .
Interestingly, reanalysis of published data indicated that tumor-specific CD8 TILs knock-out for Tox down-regulated the signature of the exhausted state and up-regulated the EM-like signature (and the memory-like signature to a lesser extent, Supplemental Our flow cytometry analysis revealed that the EM-like population is enriched within the Tcf1 high PD-1 intermediate CD8 TIL compartment and expresses high levels of the surface markers Ly6C, CXCR3 and ITGB7, as predicted from the transcriptomic analysis. These are novel EM-like CD8 TILs surface markers that can be useful in functional studies of this population. Ly6C is an adhesion molecule expressed by neutrophils, monocytes, dendritic cells and also in subsets of CD4 and CD8 T cells, including memory CD8 T cells (Walunas et al., 1995; Pihlgren, 1996; Cerwenka et al., 1998; Lee et al., 2013) . Interestingly, Ly6C + CD8 T cells with effector memory phenotype isolated from spleens of tumor-primed mice have shown anti-tumor activity in vitro (Piranlioglu et al., 2019) , supporting the hypothesis that tumor-specific EMlike cells are related to pre-exhaustion states. The chemokine receptor CXCR3 is important for the recruitment of T cells into inflamed peripheral tissue (Groom and Luster, 2011) and is also required by CD8 TILs for effective response to anti-PD-1 therapy (Chow et al., 2019) . As the EM-like state expressed the highest levels of CXCR3, this chemokine system might contribute to the enrichment of EM-like cells upon anti-PD-1 therapy observed in our study. The EM-like state -together with naïve cells-also showed differential expression of the integrin subunit b7 (Itgb7). At the protein level however, ITGB7 was expressed only by a subset of EM-like cells (Figure 2 C). Of note, Itgb7 was co-expressed in EM-like cells with the integrin subunit a4 (Itga4) but not with Itgae (CD103), with which ITGB7 dimerizes in tissue-resident T cells (Corgnac et al., 2018) . Instead, the a4b7 integrin has been previously shown to mediate lymphocyte migration to gut-associated lymphoid tissue and might have a different function in the context of tumors (Denucci, Mitchell and Shimizu, 2009 ).
Multiple studies have established that PD-1 blockade increases T cell infiltrations in tumors leading to improved anti-tumor control (Curran et al., 2010; Wei et al., 2017; Gubin et al., 2018; Gide et al., 2019) . Moreover, recent studies have shown that ICB promotes expansion of tumor-specific memory-like cells and their differentiation into (terminally) exhausted cells (Miller et al., 2019; Siddiqui et al., 2019) . However, it is less clear how the CD8 TIL landscape is impacted by ICB.
Our meta-analysis of bulk and single-cell transcriptomic data showed a selective enrichment of the EM-like signature (e.g. Cxcr3, Ly6c2, Ccl5, Gzmk, Itgb7) following ICB. As the EM-like is a relatively undifferentiated state, we reasoned that the EM-like signature would not be enriched upon ICB among T cells subsets that were already differentiated before treatment. Indeed, we observed that in vitro activated tumorspecific cells did not up-regulate the EM-like signature following adoptive transfer and ICB but instead up-regulated the exhaustion signature (e.g. Mt1, Havcr2, Prf1, Gzmb, etc., Supplemental Figure 6 B, sequencing data from (Mognol et al., 2017) ). This suggests that the enrichment in EM-like cells upon ICB depends on the expansion of relatively undifferentiated clones whereas tumor-specific T cells that have already activated the exhaustion program will only progress further towards exhaustion in response to ICB. In line with our observations, other studies have shown up-regulation of Cxcr3, Ccl5 and Ifit3 (EM-like state genes) or expansion of PD-1 low CD8 T cells (that partially contain EM-like cells, Figure 4 D) among CD8 TILs following ICB in murine models Kurtulus et al., 2019) . In humans, a CD8 TIL subset differentially expressing GZMK and CXCR3 (EM-like state markers) has been previously observed in scRNA-seq analysis of basal and squamous cell carcinoma (Yost et al., 2019) , hepatocellular carcinoma (Kang et al., 2017) and small-cell lung cancer (Guo et al., 2018) , suggesting that a similar population might be conserved between mice and human. However, in these studies tumor specificity was unknown, limiting our understanding of EM-like TILs in cancer patients. Our results will facilitate future investigations aimed at defining the function of intratumoral EM-like cells, which may provide novel markers of T cell response to immune checkpoint blockade.
In conclusion, our scRNA-seq study defined a reference map of the transcriptomic landscape of CD8 TILs in B16 melanoma. As such, this resource provides a base upon which to interpret more complex CD8 TIL transcriptomic landscapes such as those derived from clinical samples, where T cell specificity and clonality are usually unknown. Our CD8 TIL state predictor is available as an R package at https://github.com/carmonalab/TILPRED and a streamlined web interface for exploring our scRNA-seq data is available at https://tilatlas.shinyapps.io/B16_CD8TIL_10X/.
MATERIALS AND METHODS
Mice
For scRNA-seq 6-12 week-old male C57BL/6 mice (CD45.1 + ) and PMEL (Jackson Laboratory, Cat#005023) were bred and housed under SPF conditions in the conventional animal facility of the University of Lausanne. Experiments were performed in compliance with the University of Lausanne Institutional regulations and were approved by the veterinarian authorities of the Canton de Vaud.
Tumor experiments and isolation of TILs
Right flanks of mice (C57BL/6 or PMEL) were shaved and B16F10 cells (2.5x10 5 )
were injected subcutaneously. Tumor volumes were estimated by measuring the tumor size in two dimensions using a caliper. The tumor volume was calculated according to the formula (length x width 2 )/2. Mice were sacrificed at the indicated time point and the weight of the excised tumor mass was determined. mean reads per cell) and single cell 5' gene counting using default parameters and mouse genome assembly mm10.
Single-cell TCR sequencing and analysis
Intratumoral CD8 T cells cDNAs that were generated as an intermediate step during For each mouse separately, T cells sharing identical alpha and beta TCR chains were assigned to a unique clonotypes ID. PMEL-specific cells were identified based on expression of the transgenic PMEL-specific TCR (CASSFHRDYNSPLYF and CAVNTGNYKYVF for beta and alpha CDR3s, respectively, (Overwijk et al., 2003) , TCR repertoire similarity between mice (Supplemental Figure 5 A) and TIL states (Figure 3 B) was calculated using the Morisita-Horn (MH) index as implemented in the R package 'divo' (Rempala and Seweryn, 2013) .
Processing, dimensionality reduction and clustering of newly generated scRNAseq data
A total of 7174 single-cell transcriptomes were obtained from 7 samples (4 WT + 3 PMEL mice) after Cell Ranger pre-processing and UMI quantification. Next, UMI counts were normalized by dividing them by the total UMI counts in each cell and multiplying by a factor of 10,000. Then, we took the log of the normalized UMI counts prior sum of 1 (log normalized UMI counts+1). Then, cells were filtered based on quality control and expression of CD8 T cell markers to remove low-quality cells, doublets and contaminating non CD8 T cells, as follows. Upon examination of parameters distributions, we filtered out cells having less than 1,500 or more than 30,000 UMIs; cells having less than 1,500 or more than 5,000 detected genes, cells in which ribosomal protein coding genes represented more than 50% of UMI content and cells in which mitochondrial protein coding genes represented more than 5% of UMI content. The 5542 quality-passed cells were further filtered based on expression of CD8 T cells markers: 3574 cells expressing Cd8a, Cd8b1 and Cd2 but not Cd4 were kept for further analysis (processed data available as supplementary file in GEO entry).
For dimensionality reduction, we first identified the set of most variable genes using Seurat 2.3.4 method 'mean.var.plot' (using 20 bins, minimum mean expression = 0.25 and z-score threshold for dispersion = 0), which identified 1107 highly variable genes while controlling for the relationship between variability and average expression.
Briefly, this method divides genes into 20 bins based on average expression, and then calculates z-scores for dispersion (calculated as log(variance/mean)) within each bin.
From this initial set of highly variable genes, we removed 204 genes involved in cell (Scrucca et al., 2016) ), indicated high agreement between the three clustering results (Rand Index 0.70-0.81).
Moreover, this analysis indicated that the SNN clustering produced the most consistent result with the other two (with Rand Index of 0.81 against hierarchical and 0.76 against K-means, while K-means vs hierarchical had 0.7), and therefore was kept as the final clustering solution.
Gene Signature analysis
To obtain cluster-specific gene signatures, we performed differential expression analysis of each cluster against the others using MAST (Finak et al., 2015) with default parameters, and further required that for each cluster, differentially expressed genes had a log fold-change higher than 0.25, were expressed at least in 10% of its cells, and that this fraction is at least 10% higher than in the other clusters. Lists of differentially expressed genes in each cluster can be found in Supplemental Table 1 .
To identify cycling cells we evaluated enrichment of the cell cycle signature (Supplemental Table 2 ) in each cell, using the Area Under the Curve (AUC) method implemented in AUCell Bioconductor's package (Aibar et al., 2017) . Briefly, the AUC value represents the fraction of genes, within the top 1500 genes in the ranking (ordered by decreasing expression) that are included in the signature. Upon examination of AUCs distribution, we set an AUC cut-off of 0.2 for cell cycling classification (which corresponded to a z-score of ~2.5).
For CD8 T cell subtypes reference signature enrichment analysis, we first collected different T cell signatures from literature and generated other signatures by performing differential expression analysis (using Geo2R NCBI Gene Expression Omnibus tool, with default parameters) from public transcriptomic datasets. Cut-off values for log fold-change (between 1 and 3) and adjusted p-value (either 0.05 or 0.01) were set in order to obtain gene sets of similar size (in the order of a hundred genes), as described below. The list of genes in each signature can be found in Supplemental Table 2 . For cell cycle signature we used the gene set (cellCycle_union, Supplemental Table 2) obtained by combining the G1/S and G2/M signature genes from (Tirosh et al., 2016) (cellCycle, Supplemental Table 2) with the set of genes whose expression in our dataset were highly correlated with cell-cycle related genes (Pearson's correlation > 0.5, cellCycleCorrelated, Supplemental Table 2 ).
To evaluate associations (overlap) between cluster signatures and reference signatures To evaluate enrichment of EM-like, memory-like and exhausted signatures in public bulk RNA-seq data of CD8 T cells upon PD-1 blockade or TOX KO, we performed signature enrichment analysis (GSEA) using Bioconductor package clusterProfiler with default parameters (version 3.10.1, (Yu et al., 2012) ). Reads were pre-filtered using Trimmomatic v0.39 (Bolger, Lohse and Usadel, 2014) ; transcript abundances were estimated using Salmon v0.14.0 (Patro et al., 2017) with default parameters and mouse reference transcriptome version GRCm38, summarized at gene-level using tximport v1.10.1 (Soneson, Love and Robinson, 2015) and differential gene expression analysis was conducted using DESeq2 v1.22.2 with default parameters (Love, Huber and Anders, 2014) . RNA-seq data of CD8 TILs in murine sarcoma (tumors were harvested at day 12 post-transplant, 3 days after treatment) was obtained from GEO accession GSE62771 (anti-PD-1 vs control) (Gubin et al., 2014) . RNA-seq data of CD8 TILs in non-small cell lung cancer (anti-PD1 vs control) were obtained from GEO accession GSE114300 (Markowitz et al., 2018) . RNA-seq data from adoptively transferred (in vitro activated) OT-1 cells infiltrating B16-OVA tumors (anti-PD1 vs control) were obtained from GEO GSE93014 (Mognol et al., 2017) . Differential expression data from tumor-specific CD8 TILs (liver cancer) knockout for TOX (TOX-KO) vs wildtype were obtained from Supplementary Table 1 of (Scott et al., 2019) .
Cluster validation using independent dataset
To confirm the robustness of the transcriptomic states identified in our data, we reanalyzed an independent publicly available single-cell RNA-seq dataset of ~400 CD8
TILs from B16 melanoma tumors . Gene expression data processing and clustering was conducted in the same way as described for our dataset.
Consistently, four distinct transcriptomic states were identified corresponding to naïve, terminal exhausted, memory-like and EM-like populations (Supplemental Figure 3 A,   B ), plus a cluster of cycling cells in proximity to exhausted and memory-like cells.
Despite the different technologies used (smart-seq2 vs 10X 5' counting) we found a remarkable correspondence between the CD8 TIL states identified in the two datasets, 
Flow Cytometry Analysis of CD8 TILs
For the flow cytometry analysis purified CD8 cells specific for the surrogate tumor antigen LCMV gp33 (P14) were adoptively transferred (10 6 cells) into naive C57BL/6 (B6) mice (CD45.1). One day later, mice were implanted subcutaneously with B16 melanoma cells expressing LCMV gp33 (B16-gp33). Tumors were excised post 12 days of tumor engraftment and tumor infiltrating T cells were isolated as described above. Surface staining was performed with mAbs for 30 min at 4°C in PBS supplemented with 2% FCS and 0.01% azide (FACS buffer) using antibodies listed in table below.
For intranuclear staining cells were first stained at the surface before fixation and permeabilization using the transcription factor staining kit (eBioscience) followed by intranuclear staining for transcription factor.
Flow cytometry measurements of cells were performed on an LSR-II or Fortessa flow cytometer (BD 
Construction and validation of the Tumor-infiltrating CD8 T cell transcriptomic state predictor (TILPRED)
Integrated knowledge on CD8 tumor-infiltrating T cells states was used to develop a novel transcriptomic classifier of CD8 T cell states for mice and human (TILPRED).
A major challenge for the classification of single-cell transcriptomes across experiments is that gene expression measurements are affected by the large variability in single cell library sizes, and experimental and data processing protocols used. To overcome some of these issues, our classifier uses only gene expression rankings to quantify TIL state signature enrichment. Moreover, since cell cycle has a significant transcriptomic impact (McDavid et al., 2014; Scialdone et al., 2015; Barron and Li, 2016) , we also included cell cycle signature detection in TILPRED, which allows for quantification of cycling T cells in the different states.
To classify tumor-infiltrating CD8 T cells from single-cell RNA-seq data we first generated 12 sets of differently expressed genes (DEG) corresponding to all possible pairs between the four transcriptomic states. Differentially expression between pairs of clusters was assessed with MAST 1.8.2 using default parameters (after excluding cycling cells in all cluster, in order to avoid this confounding factor), and further filtering genes with a log fold-change higher than 0.5, expressed at least in 10% of one of the clusters, and with a cellular detection rate difference of at least 10% between clusters. Next, pairwise DEG sets were further filtered to keep those having orthologs in humans (as annotated in Ensembl 95 (Zerbino et al., 2018) , or NCBI HomoloGene 68 if orthologs missing in Ensembl).
The 12 pairwise DEG sets were then used to score all single-cells in our dataset, calculating gene set enrichment AUC (area under the 'enrichment' curve) within the top 1500 genes in the ranking, using AUCell (Aibar et al., 2017) . Next, the AUC scores for the 12 pairwise DEG (a training set of 70% of the cells) were used to train a multinomial logistic regression model with lasso penalty using R package glmnet (Friedman, Hastie and Tibshirani, 2010) with parameter alpha = 1 (lasso penalty) and
intercept set to 0. The regularization parameter lambda for the lasso was evaluated by 10-fold cross-validation using cv.glmnet function, and was set to the minimum value (lambda = e -6 ) for which the mean cross-validated error (cve) was at most 50% higher (i.e. cve = 0.539) than the minimum mean cross validation error (cve = 0.374, for lamda = 4.2 e -5 ).
Performance of the model was assessed in the test set (remaining 30% of the cells) assigning T cell state predictions to all cells where the model output (logistic response variable) was higher than 0.5 in any state (~5% of the cells did not pass the threshold and were annotated as 'unknown'); its accuracy was 0.94 ( 95% CI: 0.92, 0.95) with a mean specificity of 0.98 and a mean sensitivity of 0.90. Finally, the model was trained on the full dataset and implemented as an R package, publicly available at http://github.com/carmonalab/TILPRED.
To evaluate predictive performance in an independent dataset, we compared TILPRED predictions against the result of unsupervised clustering of the CD8 TIL dataset of (GEO GSE86042). The clustering analysis was performed in the same way as for our dataset (on the first 10 principal components of the most highly variable genes), except that instead of using a unique clustering solution (such as SNN clustering used to defined clusters in our dataset), we used as T cell states 'ground truth' the consensus between SNN, K-means and hierarchical clustering (using Ward's criteria) solutions. Classification accuracy using this dataset was 91%.
TILPRED analysis of public datasets
For prediction of CD8 TIL states in the MC38 dataset (NCBI GEO GSE122969 ), high-quality cells were filtered based on number of detected genes (between 500 and 5000), number of UMIs (1K to 50K) and percentage of UMIs mapping to mitochondrial (<10%) or ribosomal genes (<60%). CD8 T cells were further filtered by based on co-expression of Cd2, Cd8a, Cd8b1 and Cd3g (>= 1 UMI each) and lack of Cd4 expression. For the sarcoma dataset (NCBI GEO GSE122969 ), after examining distributions, high-quality cells were filtered based on number of detected genes (between 500 and 5000), number of UMIs (1.5K to 20K) and percentage of UMIs mapping to mitochondrial (<10%) or ribosomal genes (<50%). CD8 T cells were further filtered from other immune cell infiltrates based on co-expression of Cd2, Cd8a and Cd8b1 (>= 1 UMIs each), lack of Cd4 expression (0 UMI) and lack of -or low expression-of Fcer1g and Tyrobp (<2 UMIs). For both filtered datasts, TILPRED was run with default parameters.
For the prediciton of CD8 TIL states in the melanoma patients dataset (GEO GSE120575 (Sade -Feldman et al., 2018) ), high-quality cells were filtered based on number of detected genes (between 1000 and 6000) and percentage of UMIs mapping to ribosomal genes (<10%). CD8 T cells were further filtered from other immune cell infiltrates based on co-expression of CD2, CD8A, CD8B (>= 1 UMIs each), lack of CD4 expression (0 UMI) and lack of -or low expression-of FCER1G, TYROBP, SPI1, IGKC, IGJ, IGHG3 (<7 UMIs). Next, TILPRED was run using parameters set for human genes (human=TRUE) and using with lower score threshold for prediction (scoreThreshold=0.3, instead of the default 0.5), in order to increase sensitivity to weaker signals (as TILPRED was trained for mouse data). For the visualization of these data in Figure 3 , we used Seurat 2.3.4 to identifiy highly variable genes and perform dimensionality reduction using tSNE on the first 10 Principal Components computed on centered and scaled normalized expression values ( log (UMI counts / sum UMI count in cell * 10,000 + 1) ). The four CD8 TIL states (naïve, EM-like, exhausted and memory-like) as well as cycling TILs were predicted in all patients (Supplemental Figure 7A ). To evaluate compositional shifts upon therapy, we selected patients having samples before and after ICB and at least 30 cells in each sample (Supplemental Figure   7B ). Seven patients matched these criteria, 3 of which responded (P1, P7, P28) and 4 that failed to respond to ICB (P2, P3, P12, P20). Interestingly, compared to nonresponders, responders had an increased proportion of EM-like cells upon therapy For the prediction of TIL states of the Miller dataset of (B16-OVA) tumor-specific tumor-infiltrating CD8 + T cells, UMI counts matrix was obtained from GEO (accession GSE122675). Upon examination, high-quality CD8 T cells were filtered as those having between 1000 and 5000 expressed genes, 1000 and 30,000 UMI counts, less than 6% of UMI counts mapping to mitochondrial genes, less than 50% of genes mapping to ribosomal proteins coding genes, and that expressed Cd2, Cd3g, Cd8a, Cd8b1 and did not express Cd4 or high levels of Tyrobp or Spi1 (that are associated to CD4 T cells or myeloid cells, respectively). Next, cycling cells were further filtered (those with an AUC score higher than 0.1 for the 'cell cycle' signature) and cell states were predicted using TILPRED with default parameters.
WebApp deployment for scRNA-seq data exploration
Our web application uses iSEE (interactive SummarizedExperiment Explorer) (Rue-Albrecht et al., 2018) and R Shiny (https://shiny.rstudio.com), and is available at https://tilatlas.shinyapps.io/B16_CD8TIL_10X/.
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